¼¼°èÀÇ ¼öÀÇ ³»ºÐºñÇÐ ½ÃÀå
Veterinary Endocrinology
»óǰÄÚµå : 1777669
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 366 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¼¼°èÀÇ ¼öÀÇ ³»ºÐºñÇÐ ½ÃÀåÀº 2030³â±îÁö 4¾ï 2,330¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 3¾ï 1,530¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼öÀÇ ³»ºÐºñÇÐ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 4¾ï 2,330¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ °³´Â CAGR 5.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2¾ï 5,290¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °í¾çÀÌ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 3.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8,590¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR8.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼öÀÇ ³»ºÐºñÇÐ ½ÃÀåÀº 2024³â¿¡´Â 8,590¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 8,430¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 8.1%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.4%¿Í 5.0%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ¼öÀÇ ³»ºÐºñÇÐ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

¼öÀÇ ³»ºÐºñÇÐÀÌ µ¿¹° °Ç°­°ü¸®¿¡¼­ Á߿伺ÀÌ Ä¿Áö´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¼öÀÇ ³»ºÐºñÇÐÀº µ¿¹°ÀÇ È£¸£¸ó °ü·Ã ÁúȯÀ» ´Ù·ç´Â ¼öÀÇÇÐÀÇ ÇÑ ºÐ¾ß·Î, ¹Ý·Áµ¿¹°°ú °¡ÃàÀÇ ³»ºÐºñ Áúȯ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±× Á߿伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. ´ç´¢º´, °©»ó¼±±â´ÉÀúÇÏÁõ, °©»ó¼±±â´ÉÇ×ÁøÁõ, Äí½Ìº´, ¾Öµð½¼º´ µîÀÇ Áúº´Àº ¼öÀÇÇÐÀû Áø´ÜÀÇ ¹ßÀüÀ¸·Î Á¶±â ¹ß°ßÀÌ °¡´ÉÇØÁö¸é¼­ ¹Ý·Áµ¿¹°¿¡¼­ ´õ¿í ÈçÇÏ°Ô Áø´ÜµÇ°í ÀÖ½À´Ï´Ù. À¯ÀüÀû ¼ÒÀÎ, ºñ¸¸, ³ëÈ­, ȯ°æÀû ½ºÆ®·¹½º µîÀÇ ¿äÀÎÀÌ µ¿¹°ÀÇ ³»ºÐºñ Áúȯ ¹ß»ý·ü Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ µ¿¹°ÀÇ °Ç°­¿¡ ´õ ±íÀÌ °ü¿©ÇÏ°Ô µÇ¸é¼­ È£¸£¸ó ´ëü ¿ä¹ý, Àν¶¸° ¿ä¹ý, ½ÄÀÌ °ü¸® Àü·« µî ³»ºÐºñÇп¡ ƯȭµÈ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼öÀÇÇÐÀû Ä¡·áÀÇ Çâ»óÀ¸·Î ¹Ý·Áµ¿¹°ÀÇ ¼ö¸íÀÌ ±æ¾îÁü¿¡ µû¶ó ³ëÈ­¿Í °ü·ÃµÈ ³»ºÐºñ Àå¾Ö°¡ ¸¹ÀÌ ¹ß»ýÇϰí ÀÖ¾î Àå±âÀûÀÎ °ü¸® ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. °¡ÃàÀÇ °æ¿ì, È£¸£¸ó ±ÕÇüÀÌ ±úÁö¸é ¹ø½Ä·ü, ¼ºÀå, À¯·®¿¡ ¿µÇâÀ» ¹ÌÃÄ °æÁ¦ÀûÀ¸·Î ½É°¢ÇÑ °á°ú¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼öÀÇÇÐ ºÐ¾ß°¡ Àü¹®È­µÇ¸é¼­ ¼öÀÇ ³»ºÐºñÇÐÀº Áß¿äÇÑ ÁßÁ¡ ºÐ¾ß·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, È£¸£¸ó °Ç°­ÀÇ °í±Þ Áø´Ü µµ±¸, Ä¡·á ¹æ¹ý ¹× ¿¬±¸¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¼öÀÇ ³»ºÐºñÇÐÀÇ ÃֽŠÇõ½ÅÀº ¹«¾ùÀΰ¡?

¼öÀÇ ³»ºÐºñÇÐ ºÐ¾ß´Â Çõ½ÅÀûÀÎ Áø´Ü ¹× Ä¡·á Á¢±Ù¹ýÀ» ÅëÇØ È£¸£¸ó °ü·Ã Áúȯ °ü¸®ÀÇ Á¤È®¼º°ú È¿´ÉÀ» Çâ»ó½ÃŰ¸ç ±â¼úÀû Çõ½ÅÀ» °ÅµìÇϰí ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ ¹ßÀü Áß Çϳª´Â ¼öÀǻ簡 Ç÷¾× °Ë»ç¸¦ ÅëÇØ È£¸£¸ó ±ÕÇü Àå¾Ö¸¦ ½Å¼ÓÇÏ°Ô Æò°¡ÇÒ ¼ö ÀÖ´Â ÇöÀå Áø´Ü µµ±¸ÀÇ °³¹ß·Î, Áø´Ü¿¡ ÇÊ¿äÇÑ ½Ã°£À» ´ÜÃàÇÏ°í ½Å¼ÓÇÑ °³ÀÔÀÌ °¡´ÉÇØÁ³½À´Ï´Ù´Â Á¡ÀÔ´Ï´Ù. óÀ½¿¡´Â Àΰ£ÀÇ ´ç´¢º´ °ü¸®¸¦ À§ÇØ °³¹ßµÈ Áö¼ÓÀû Æ÷µµ´ç ¸ð´ÏÅ͸µ(CGM) ½Ã½ºÅÛÀº ÇöÀç ´ç´¢º´À» ¾Î°í ÀÖ´Â ¹Ý·Áµ¿¹°¿¡°Ôµµ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ½Ç½Ã°£À¸·Î Æ÷µµ´ç ¼öÄ¡¸¦ ÃßÀûÇϰí Àν¶¸° ¿ä¹ýÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯ÀüÀÚ ±â¹Ý Áø´Ü¹ýÀÇ µîÀåÀ¸·Î À¯ÀüÀÚ º¯ÀÌ¿Í °ü·ÃµÈ ³»ºÐºñ Àå¾Ö, ƯÈ÷ °©»ó¼±°ú ºÎ½Å ±â´É Àå¾Ö°¡ ¹ß»ýÇϱ⠽¬¿î ƯÁ¤ °³¿Í °í¾çÀÌ Ç°Á¾¿¡¼­ À¯ÀüÀÚ º¯ÀÌ¿Í °ü·ÃµÈ ³»ºÐºñ Àå¾Ö¸¦ °¨ÁöÇÒ ¼ö ÀÖ´Â ´É·Âµµ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¼ÓÇü Àν¶¸° À¯»çü, ¼­¹æÇü È£¸£¸ó ÀÓÇöõÆ® µîÀÇ »õ·Î¿î Á¦Á¦´Â ³»ºÐºñ Ä¡·áÀÇ È¿°ú¿Í ÆíÀǼºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¿¬±¸ÁøÀº ¶ÇÇÑ ³»ºÐºñ ±â´É Àå¾Ö, ƯÈ÷ Àν¶¸° ÀÇÁ¸¼º ´ç´¢º´°ú ºÎ½Å Àå¾Ö¿¡ ´ëÇÑ ¹Ì·¡ Ä¡·á¹ýÀ¸·Î Áٱ⼼Æ÷ Ä¡·á¸¦ Æ÷ÇÔÇÑ Àç»ý ÀǷḦ ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´ÉÀÌ ¼öÀÇ ³»ºÐºñÇп¡ ÅëÇյǸ鼭 Áúº´ °ü¸®´Â ´õ¿í Çõ½ÅÀûÀ¸·Î º¯È­Çϰí ÀÖÀ¸¸ç, AI ±â¹Ý ¾Ë°í¸®ÁòÀÌ ¼öÀǻ縦 µµ¿Í º¹ÀâÇÑ È£¸£¸ó ±ÕÇü Àå¾Ö¸¦ Áø´ÜÇϰí, °ú°Å ȯÀÚ µ¥ÀÌÅ͸¦ ±â¹ÝÀ¸·Î Ä¡·á °á°ú¸¦ ¿¹ÃøÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº µ¿¹°ÀÇ ³»ºÐºñ ÁúȯÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» Å©°Ô Çâ»ó½ÃÄÑ Àå±âÀûÀÎ °Ç°­ °á°ú¸¦ º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼öÀÇÇп¡¼­ ³»ºÐºñ Áúȯ °ü¸®ÀÇ °úÁ¦´Â?

¼öÀÇ ³»ºÐºñÇÐÀÇ ¹ßÀü¿¡µµ ºÒ±¸ÇÏ°í ³»ºÐºñ ÁúȯÀÇ Áø´Ü°ú °ü¸®¿¡´Â ¿©ÀüÈ÷ ¸î °¡Áö °úÁ¦°¡ ³²¾Æ ÀÖ½À´Ï´Ù. °¡Àå Å« ¾î·Á¿ò Áß Çϳª´Â È£¸£¸ó ±ÕÇü Àå¾Ö¸¦ Áø´ÜÇÏ´Â °ÍÀÌ º¹ÀâÇÏ´Ù´Â °ÍÀÔ´Ï´Ù. ¸¹Àº ³»ºÐºñ ÁúȯÀº ´Ù¸¥ Áúȯ°ú Áߺ¹µÇ´Â ºñƯÀÌÀûÀÎ Áõ»óÀ» º¸À̱⠶§¹®ÀÔ´Ï´Ù. ÀÌ ¶§¹®¿¡ ƯÈ÷ Ãʱ⿡´Â Áø´ÜÀÌ ´Ê¾îÁö°Å³ª ¿ÀÁøµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶Ç ´Ù¸¥ Å« °úÁ¦´Â ´ç´¢º´, °©»ó¼± ±â´É ÀúÇÏÁõ µî ¸¹Àº ³»ºÐºñ ÁúȯÀº Æò»ý °ü¸®°¡ ÇÊ¿äÇϰí, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú ¾ö°ÝÇÑ º¹¾à ¼øÀÀµµ°¡ ¿ä±¸µÈ´Ù´Â Á¡ÀÔ´Ï´Ù. Åõ¾à, Áø´Ü °Ë»ç, °æ°ú °üÂûÀ» Æ÷ÇÔÇÑ Àå±â Ä¡·á ºñ¿ëÀº º¸È£ÀÚ¿¡°Ô Å« ºÎ´ãÀ¸·Î ÀÛ¿ëÇÏ¿© ¼øÀÀµµ ¹× Ä¡·á Áß´ÜÀÇ ¹®Á¦·Î À̾îÁý´Ï´Ù. Ãà»ê¾÷°è¿¡¼­´Â È£¸£¸ó Ä¡·á¿Í ½Äǰ ³» ÀÜ·ù °¡´É¼ºÀÌ ½Äǰ ¾ÈÀü°ú ±ÔÁ¦ Áؼö¿¡ ´ëÇÑ ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Å°°í, ½Ä¿ë µ¿¹°¿¡ ´ëÇÑ È£¸£¸ó »ç¿ë¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦¸¦ ¾ß±âÇϰí ÀÖ½À´Ï´Ù. ÀÏ¹Ý ¼öÀǻ簡 Ç×»ó °í±Þ ³»ºÐºñÇÐ ±³À° ¹× Áø´Ü ÀÚ¿øÀ» ÀÌ¿ëÇÒ ¼ö ÀÖ´Â °ÍÀº ¾Æ´Ï±â ¶§¹®¿¡ ³»ºÐºñÇÐ Àü¹® ¼öÀÇ»çÀÇ °¡¿ë¼ºÀÌ Á¦ÇÑÀûÀ̶ó´Â Á¡µµ À庮À¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¿¹°ÀÇ È£¸£¸ó ¿ä¹ý, ƯÈ÷ »ý½Ä °ü¸® ¹× ¼ºÀå ÃËÁø¿¡ ´ëÇÑ À±¸®Àû Àǹ̿¡ ´ëÇÑ ÇöÀç ÁøÇà ÁßÀÎ ³íÀÇ´Â ÀÌ ºÐ¾ß¿¡ »õ·Î¿î º¹À⼺À» ´õÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ±Øº¹Çϱâ À§Çؼ­´Â Áö¼ÓÀûÀÎ ¿¬±¸, Áø´Ü ¹æ¹ýÀÇ °³¼±, µ¿¹° ³»ºÐºñ °Ç°­ÀÇ Á߿伺¿¡ ´ëÇÑ ¼öÀÇ»ç¿Í º¸È£ÀÚÀÇ ÀÎ½Ä °³¼±ÀÌ ÇÊ¿äÇÕ´Ï´Ù.

¼öÀÇ ³»ºÐºñÇÐ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

¼öÀÇ ³»ºÐºñÇÐ ½ÃÀåÀÇ ¼ºÀåÀº Áø´Ü ±â¼úÀÇ ¹ßÀü, ¹Ý·Áµ¿¹°ÀÇ ¼ö¸í ¿¬Àå, ³»ºÐºñ °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ¹Ý·Áµ¿¹°ÀÇ ³»ºÐºñ ÁúȯÀÇ À¯º´·ü Áõ°¡·Î, º¸´Ù Àü¹®ÀûÀÎ ¼öÀÇÇÐÀû Ä¡·á°¡ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. µ¿¹°À» À§ÇÑ Á¾ÇÕÀûÀÎ °Ç°­°ü¸® ¼Ö·ç¼ÇÀ» ã´Â º¸È£ÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ³»ºÐºñ °ü·Ã Áø´Ü, Åõ¾à, Àü¹® ¼öÀÇÇÐ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼­¹æÇü È£¸£¸ó ÀÓÇöõÆ®, Á¤¹ÐÀÇ·á Á¢±Ù¹ý µî »õ·Î¿î Ä¡·á¹ý °³¹ßµµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¼öÀÇÇÐ ¿ø°ÝÀÇ·áÀÇ ¿µÇâ·ÂÀÌ Ä¿Áö¸é¼­, ƯÈ÷ ¿ø°ÝÁö³ª ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ³»ºÐºñÇÐ Áø·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿øÇコ(One Health)ÀÇ Æ² ¾È¿¡¼­ Àΰ£°ú ¼öÀÇÇÐÀÇ Çù·ÂÀÌ ÁøÇàµÊ¿¡ µû¶ó ³»ºÐºñ Áúȯ °ü¸®ÀÇ Áøº¸¸¦ °¡¼ÓÈ­ÇÏ´Â ´ÙÇÐÁ¦Àû ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ³»ºÐºñ ÁúȯÀ» Æ÷ÇÔÇÑ ¸¸¼º Áúȯ¿¡ ´ëÇÑ ¹Ý·Áµ¿¹° º¸Çè Àû¿ë ¹üÀ§°¡ È®´ëµÇ¸é¼­ ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ Àå±âÀûÀÎ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´õ ¸¹ÀÌ Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ãà»ê ºÐ¾ßÀÇ »ý»ê¼º Çâ»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â ¹ø½Ä È¿À²°ú ¼ºÀå·üÀ» ÃÖÀûÈ­Çϴ ȣ¸£¸ó ±â¹Ý Ä¡·á¹ý¿¡ ´ëÇÑ ¿¬±¸¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸¿Í ±â¼ú¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ¸¦ ÅëÇØ µ¿¹° ³»ºÐºñ °ü·Ã Áúȯ¿¡ ´ëÇÑ º¸´Ù Á¤È®Çϰí È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ¼öÀÇ ³»ºÐºñÇÐ ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ºÎ¹®

µ¿¹° À¯Çüº°(°ß, °í¾çÀÌ, ±âŸ µ¿¹°)£»¿ëµµº°(ÃéÀå Áúȯ, ±âŸ Áúȯ)£»Åõ¿© °æ·Î(°æ±¸, ±âŸ °æ·Î)

ºÐ¼® ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts¿¡¼­´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Veterinary Endocrinology Market to Reach US$423.3 Million by 2030

The global market for Veterinary Endocrinology estimated at US$315.3 Million in the year 2024, is expected to reach US$423.3 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Dogs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$252.9 Million by the end of the analysis period. Growth in the Cats segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$85.9 Million While China is Forecast to Grow at 8.1% CAGR

The Veterinary Endocrinology market in the U.S. is estimated at US$85.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$84.3 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Veterinary Endocrinology Market - Key Trends & Drivers Summarized

Why Is Veterinary Endocrinology Gaining Importance in Animal Healthcare?

Veterinary endocrinology, the branch of veterinary medicine that deals with hormone-related disorders in animals, has been gaining increasing importance due to the rising prevalence of endocrine disorders in companion and livestock animals. Conditions such as diabetes mellitus, hypothyroidism, hyperthyroidism, Cushing’s disease, and Addison’s disease are becoming more commonly diagnosed in pets, particularly as advancements in veterinary diagnostics improve early detection. Factors such as genetic predisposition, obesity, aging, and environmental stressors contribute to the rising incidence of endocrine disorders in animals. As pet owners become more invested in their animals’ health, there is a growing demand for specialized endocrinology treatments, including hormone replacement therapy, insulin therapy, and dietary management strategies. Additionally, the increasing lifespan of companion animals due to better veterinary care has led to a higher occurrence of age-related endocrine disorders, necessitating long-term management solutions. In livestock, hormonal imbalances can have significant economic consequences, affecting reproduction rates, growth, and milk production, making veterinary endocrinology crucial for ensuring optimal farm productivity. With the veterinary field becoming more specialized, endocrinology is emerging as a key focus area, driving demand for advanced diagnostic tools, treatment modalities, and research in hormonal health.

What Are the Latest Innovations in Veterinary Endocrinology?

The field of veterinary endocrinology is undergoing a technological transformation, with innovative diagnostic and treatment approaches improving the accuracy and effectiveness of hormone-related disease management. One of the most significant advancements is the development of point-of-care diagnostic tools that allow veterinarians to quickly assess hormonal imbalances through blood tests, reducing the time needed for diagnosis and enabling immediate intervention. Continuous glucose monitoring (CGM) systems, initially developed for human diabetes management, are now widely used in diabetic pets, providing real-time glucose level tracking and optimizing insulin therapy. The rise of gene-based diagnostics is also enhancing the ability to detect endocrine disorders linked to genetic mutations, particularly in specific dog and cat breeds prone to thyroid or adrenal gland dysfunction. Additionally, novel drug formulations, such as long-acting insulin analogs and slow-release hormonal implants, are improving the effectiveness and convenience of endocrine treatments. Researchers are also exploring regenerative medicine, including stem cell therapy, as a potential future treatment for endocrine dysfunctions, particularly in insulin-dependent diabetes and adrenal gland disorders. The integration of artificial intelligence into veterinary endocrinology is further revolutionizing disease management, with AI-powered algorithms assisting veterinarians in diagnosing complex hormonal imbalances and predicting treatment outcomes based on historical patient data. These technological advancements are significantly enhancing the ability to manage endocrine disorders in animals, ensuring better long-term health outcomes.

What Are the Challenges in Managing Endocrine Disorders in Veterinary Medicine?

Despite the progress in veterinary endocrinology, several challenges persist in the diagnosis and management of endocrine disorders. One of the primary difficulties is the complexity of diagnosing hormonal imbalances, as many endocrine disorders present with non-specific symptoms that overlap with other medical conditions. This often results in delayed or misdiagnosed cases, particularly in early disease stages. Another major challenge is the lifelong management required for many endocrine disorders, such as diabetes mellitus and hypothyroidism, which necessitate continuous monitoring and strict medication adherence. The cost of long-term treatment, including medications, diagnostic testing, and follow-up consultations, can be a significant burden for pet owners, leading to issues of compliance and treatment discontinuation. In the livestock industry, hormonal treatments and their potential residues in food products raise concerns about food safety and regulatory compliance, leading to strict regulations on hormone usage in food-producing animals. The limited availability of veterinary specialists in endocrinology also presents a barrier, as general veterinarians may not always have access to advanced endocrinology training and diagnostic resources. Furthermore, ongoing debates surrounding the ethical implications of hormone therapy in animals, particularly in reproductive management and growth enhancement, add another layer of complexity to the field. Overcoming these challenges requires continuous research, improved diagnostic methodologies, and increased awareness among both veterinarians and pet owners about the importance of endocrine health in animals.

What Are the Key Growth Drivers of the Veterinary Endocrinology Market?

The growth in the veterinary endocrinology market is driven by several factors, including advancements in diagnostic technology, increasing pet lifespan, and rising awareness about endocrine health. One of the major drivers is the increasing prevalence of endocrine disorders in companion animals, necessitating more specialized veterinary care. As more pet owners seek comprehensive healthcare solutions for their animals, there is a growing demand for endocrine-related diagnostics, medications, and specialized veterinary services. The development of novel treatment modalities, such as sustained-release hormonal implants and precision medicine approaches, is also fueling market expansion. The growing influence of veterinary telemedicine is playing a significant role in expanding access to endocrinology consultations, particularly in remote and underserved regions. Additionally, the increasing collaboration between human and veterinary medicine under the One Health framework is leading to cross-disciplinary research that accelerates advancements in endocrine disease management. The expansion of pet insurance coverage for chronic diseases, including endocrine disorders, is further encouraging pet owners to invest in long-term treatment solutions. Furthermore, the demand for productivity-enhancing solutions in livestock farming is propelling research into hormone-based treatments that optimize reproductive efficiency and growth rates. With continued investment in research and technology, the veterinary endocrinology market is expected to see sustained growth, offering more precise and effective treatment options for endocrine-related conditions in animals.

SCOPE OF STUDY:

The report analyzes the Veterinary Endocrinology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Dogs, Cats, Other Animals); Application (Pancreatic Disorders, Other Disorders); Administration Route (Oral, Other Routes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â